WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009142588) COMBINATION OF (A) A CHEMOKINE RECEPTOR 1 (CCR1) ANTAGONIST AND (B) GLUCOCORTICOID RECEPTOR MODULATOR
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/142588    International Application No.:    PCT/SE2009/050563
Publication Date: 26.11.2009 International Filing Date: 19.05.2009
IPC:
A61K 31/438 (2006.01), A61K 31/407 (2006.01), A61K 31/4468 (2006.01), A61P 11/00 (2006.01)
Applicants: ASTRAZENECA AB [SE/SE]; S-151 85 Södertälje (SE) (For All Designated States Except US).
BAYER SCHERING PHARMA AG [DE/DE]; Müllerstr. 178 D-13353 Berlin (DE) (For All Designated States Except US).
ERIKSSON, Tomas [SE/SE]; (SE) (For US Only).
MENSONIDES-HARSEMA, Marguerite [NL/SE]; (SE) (For US Only)
Inventors: ERIKSSON, Tomas; (SE).
MENSONIDES-HARSEMA, Marguerite; (SE)
Agent: ASTRAZENECA AB; AstraZeneca Intellectual Property S-151 85 Södertälje (SE)
Priority Data:
61/054,593 20.05.2008 US
Title (EN) COMBINATION OF (A) A CHEMOKINE RECEPTOR 1 (CCR1) ANTAGONIST AND (B) GLUCOCORTICOID RECEPTOR MODULATOR
(FR) COMBINAISON DE: (A) UN ANTAGONISTE DU RÉCEPTEUR 1 DE LA CHIMIOKINE (CCR1) ET (B) UN MODULATEUR DES RÉCEPTEURS DES GLUCOCORTICOÏDES
Abstract: front page image
(EN)The present invention relates to a combination of (a) a chemokine receptor 1 (CCRl) antagonist and (b) a glucocorticoid receptor modulator. The invention further relates to pharmaceutical compositions comprising said combination and to methods of treatment of airway diseases, such as chronic obstructive pulmonary disease (COPD) and asthma in mammals by administrating said combination. The invention also relates to a kit comprising the combination and use of said kit in treatment of airway diseases.
(FR)La présente invention concerne une combinaison de: (a) un anatagoniste du récepteur 1 de la chimiokine (CCR1) et (b) un modulateur des récepteurs des glucocorticoïdes. L'invention concerne également des compositions pharmaceutiques comprenant ladite combinaison ainsi que des méthodes de traitement de maladies des voies respiratoires, telles que la bronchopneumopathie chronique obstructive (BPCO) et l'asthme chez des mammifères par administration de ladite combinaison. L'invention concerne en outre un kit comprenant la combinaison et l'utilisation dudit kit dans le traitement de maladies des voies respiratoires.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)